Dr. Jeffrey Jones on Idelalisib and Ibrutinib in Patients With CLL
Jeffrey Jones, MD, discusses treatment options for patients with chronic lymphocytic leukemia (CLL) who progress on, or become intolerant of, idelalisib or ibrutinib during their treatment.
Dr. Jeffrey Jones on the Efficacy of Venetoclax in Treatment for CLL
Jeffrey Jones, MD, discusses small molecule inhibitors of B-cell receptor signaling in chronic lymphocytic leukemia (CLL).